A1

AMDG 1

Description

AMDG 1

Investor Profile

AMDG 1 has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Nanotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AMDG 1 frequently co-invest with?

Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 1
Sovereign’s Capital
North America, Georgia, United States, Atlanta
Co-Investments: 1
Co-Investments: 1
Eshelman Ventures
North America, North Carolina, United States, Wilmington
Co-Investments: 1

What are some of recent deals done by AMDG 1?

Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquityDec 26, 2019
Amount Raised: $22,400,000